Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2021

The following is a summary of the Company’s stock option activity and related information (options in thousands):


	Year Ended December 31, 2021
	Options	Weighted Average Exercise Price
Outstanding, beginning of period	3,599	$	22.01
Granted	943	22.52
Exercised	(388)	14.63
Forfeited	(797)	25.33
Outstanding, end of period	3,357	22.22
Exercisable	1,574	23.22

Summary of Restricted Stock Units Activity

The following is a summary of the Company’s RSU activity and related information (RSUs in thousands):


	Year Ended December 31, 2021
	RSUs	Weighted Average Fair Value
Outstanding, beginning of period	488	$	23.88
Awarded	385	23.40
Vested	(210)	24.10
Forfeited	(135)	23.33
Outstanding, end of period	528	23.58

Summary of Performance Stock Units Activity

The Company has granted Performance Stock Units (“PSUs”), which are subject to service, performance, and market-based vesting conditions. The following is a summary of the Company’s PSU activity and related information (PSUs in thousands):


	Year Ended December 31, 2021
	PSUs	Weighted Average Fair Value
Outstanding, beginning of period	130	$	15.94
Awarded	188	24.99
Forfeited	(49)	21.93
Outstanding, end of period	269	21.16

Intersect ENT, Inc. 10-K